IFF’s probiotics portfolio emphasizes clinically studied strain combinations. Johanna Maukonen, global director for clinical innovation and translation, and Jennifer Montgomery, IFF Health Sciences global marketing leader, discussed how IFF approaches designing and validating these formulas to ensure consistent benefits in real-world use, while sharing insights on key advances in the expanding field of probiotics for oral health.
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement

















